COLLEEN F. REITAN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ALNYLAM PHARMACEUTICALS, INC.

Filing Date Source Excerpt
2019-03-21 Ms. Reitan brings to our board over 30 years of experience in the healthcare payer and reimbursement market, including most recently as President of Plan Operations of HCSC.
2020-03-23 Ms. Reitan brings to our board over 30 years of experience in the healthcare payer and reimbursement market, including most recently as President of Plan Operations of HCSC.
2021-04-02 Ms. Reitan served as President of Plan Operations of Health Care Service Corporation, the largest customer-owned health insurer in the United States.
2022-04-05 Ms. Reitan brings to our board over 30 years of experience in the healthcare payer and reimbursement market, including most recently as President of Plan Operations of HCSC.
2023-04-03 Ms. Reitan brings to our board over 30 years of experience in the healthcare payer and reimbursement market, including most recently as President of Plan Operations of HCSC.
2025-03-24 Ms. Reitan brings to our board over 30 years of experience in the healthcare payor and reimbursement market, including most recently as President of Plan Operations of HCSC. Ms. Reitan’s experience with provider network management, strategic planning and business development provide valuable insight to our board and management.

MYRIAD GENETICS INC

Filing Date Source Excerpt
2019-10-16 Colleen F. Reitan (1) 59 Director ... Member of the Audit Committee ... The following table shows the total compensation paid or accrued during the fiscal year ended June 30, 2019 to each of our nonemployee directors ... Colleen F. Reitan 0 Fees Earned or Paid in Cash, 0 Restricted Stock Unit Awards, 0 Total.
2020-10-15 Colleen F. Reitan was appointed as a member of the Board of Directors in September of 2019... The Audit and Finance Committee currently has six members: Mr. Spiegelman (chair), Mr. Best, Ms. Kumar, Dr. Langer, Ms. Phanstiel, and Ms. Reitan... The Nominating and Governance Committee currently has four members: Dr. Langer (chair), Dr. Henderson, Ms. Phanstiel, and Ms. Reitan... The following table shows the total compensation paid or accrued during the fiscal year ended June 30, 2020 to each of our nonemployee directors... Colleen F. Reitan 73,313 300,005 373,318
2021-04-15 Colleen F. Reitan was appointed as a member of the Board of Directors in September of 2019... Age: 61... Director Compensation Table: Colleen F. Reitan Fees Earned or Paid in Cash: 56,500, Stock Awards: 299,984, Total: 356,484.
2022-04-14 Colleen F. Reitan was appointed as a member of the Board of Directors in September 2019. Ms. Reitan previously held numerous senior leadership positions at Health Care Services Corporation (HCSC) including most recently as the Executive Vice President and President of Plan Operations and as the Chief Operating Officer. Prior to working at HCSC, Ms. Reitan held numerous senior management positions at Blue Cross and Blue Shield of Minnesota including President and Chief Operating Officer. In aggregate, Ms. Reitan has over 35 years of experience in the managed care industry. Ms. Reitan holds a B.A. from Minnesota State University at Mankato and a M.S. in Health Care Administration from the University of Minnesota-Twin Cities. She currently serves on the board of Alnylam Pharmaceuticals, Inc. The Board of Directors has determined that Ms. Reitan should serve on the Board for the following reasons: Her extensive reimbursement and managed care experience will aid the Company in its efforts to expand reimbursement for its new innovative precision medicine tests. Furthermore, she provides the Board with important expertise on the medical insurance industry based on her extensive experience in several senior positions at Health Care Services Corporation and Blue Cross and Blue Shield of Minnesota. In addition, she provides the Board with management expertise, resulting from managing private companies and serving as a director of a publicly-traded company. Age: 62 Director Since:2019 Committees: Audit and Finance Committee, Nominating, Environmental, Social and Governance Committee
2023-04-12 Colleen F. Reitan was appointed as a member of the Board in September 2019. Ms. Reitan previously held numerous senior leadership positions at Health Care Services Corporation (HCSC) including most recently as the Executive Vice President and President of Plan Operations and as the Chief Operating Officer. Prior to working at HCSC, Ms. Reitan held numerous senior management positions at Blue Cross and Blue Shield of Minnesota including President and Chief Operating Officer. In aggregate, Ms. Reitan has over 35 years of experience in the managed care industry. Ms. Reitan holds a B.A. from Minnesota State University at Mankato and a M.S. in Health Care Administration from the University of Minnesota-Twin Cities. She currently serves on the board of Alnylam Pharmaceuticals, Inc. The Board has determined that Ms. Reitan should serve on the Board for the following reasons: Her extensive reimbursement and managed care experience will aid the Company in its efforts to expand reimbursement for its new innovative precision medicine tests. Furthermore, she provides the Board with important expertise on the medical insurance industry based on her extensive experience in several senior positions at Health Care Services Corporation and Blue Cross and Blue Shield of Minnesota. In addition, she provides the Board with management expertise, resulting from managing private companies and serving as a director of a publicly-traded company.
2024-04-17 Colleen F. Reitan was appointed as a member of the Board in September 2019... The following table shows the total compensation paid or accrued during the year ended December 31, 2023 to each of our non-employee directors who served during fiscal year 2023... Colleen F. Reitan $93,500 cash fees and $349,988 stock awards totaling $443,488.

Data sourced from SEC filings. Last updated: 2026-02-03